Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001067555 | SCV001232622 | pathogenic | Epilepsy, familial focal, with variable foci 3 | 2023-11-27 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu117Lysfs*5) in the NPRL3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NPRL3 are known to be pathogenic (PMID: 26285051, 26505888). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with nonlesional generalized epilepsy (PMID: 28726809). ClinVar contains an entry for this variant (Variation ID: 861113). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV003159179 | SCV003853120 | pathogenic | not provided | 2024-08-29 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31028937, 28726809, 34926809, 35136953) |
OMIM | RCV001067555 | SCV003841172 | pathogenic | Epilepsy, familial focal, with variable foci 3 | 2023-03-02 | no assertion criteria provided | literature only |